Neural correlates of symptom reduction after CBT in obsessive-compulsive washers-An fMRI symptom provocation study

Journal of Obsessive-Compulsive and Related Disorders

Volumn 2, Issue 3, 2013, Pages 322-330

  Baioui, Ali ^a   Pilgramm, Juliane ^a   Kagerer, Sabine ^a   Walter, Bertram ^a   Vaitl, Dieter ^a   Stark, Rudolf ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

CBT; FMRI; Individualization; OCD; Psychotherapy; Symptom provocation

Indexed keywords

ADULT; ARTICLE; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; COGNITIVE THERAPY; COMPULSION; CONTROLLED STUDY; CORRELATION ANALYSIS; EFFECT SIZE; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HAND WASHING; HUMAN; INFORMATION PROCESSING; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROLOGIC DISEASE; NUCLEUS ACCUMBENS; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROVOCATION; PSYCHOTHERAPY; QUESTIONNAIRE FOR ASSESSMENT OF DISGUST SENSITIVITY; STATE TRAIT ANXIETY INVENTORY; STRIATE CORTEX; SUPRAMARGINAL GYRUS; SYMPTOM; TREATMENT OUTCOME; VISUAL STIMULATION; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

EID: 84880381384     PISSN: 22113649     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocrd.2013.04.006     Document Type: Article

References (76)

1. Abramowitz J.S., Foa E.B., Franklin M.E. Exposure and ritual prevention for obsessive-compulsive disorder: Effects of intensive versus twice-weekly sessions. Journal of Consulting and Clinical Psychology 2003, 71(2):394-398.
2. Baioui A., Pilgramm J., Merz C.J., Walter B., Vaitl D., Stark R. Neural response in obsessive-compulsive washers depends on individual fit of triggers. Frontiers in Human Neuroscience 2013, 7:143. 〈10.3389/fnhum.2013.00143〉.
3. Baxter, L. R., Jr., Schwartz, J. M., Bergman, K. S., Szuba, M. P., Guze, B. H., Mazziotta P., et al. (1992). Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder, Archives of General Psychiatry 49 (9), 681-689.
4. Beauregard M. Mind does really matter: Evidence from neuroimaging studies of emotional self-regulation, psychotherapy, and placebo effect. Progress in Neurobiology 2007, 81(4):218-236.
5. Beck A.T., Steer R.A., Brown G.K. Manual for Beck depression inventory-II 1996, Psychological Corporation, San Antonio, TX.
6. Benkelfat C., Nordahl T.E., Semple W.E., King A.C., Murphy D.L., Cohen R.M. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: patients treated with clomipramine. Archives of General Psychiatry 1990, 47(9):840-848. 10.1001/archpsyc.1990.01810210048007.
7. Chamberlain S.R., Blackwell A.D., Fineberg N.A., Robbins T.W., Sahakian B.J. The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers. Neuroscience and Biobehavioral Reviews 2005, 29(3):399-419.
8. Chen X.-L., Xie J.-X., Han H.-B., Cui Y.-H., Zhang B.Q. MR perfusion-weighted imaging and quantitative analysis of cerebral hemodynamics with symptom provocation in unmedicated patients with obsessive-compulsive disorder. Neuroscience Letters 2004, 370(2-3):206-211.
9. Cohen J. A power primer. Psychological Bulletin 1992, 112(1):155-159.
10. Deacon B.J., Abramowitz J.S. The Yale-Brown Obsessive Compulsive Scale: factor analysis, construct validity, and suggestions for refinement. Journal of Anxiety Disorders 2005, 19(5):573-585. 〈10.1016/j.janxdis.2004.04.009〉.
11. Deckersbach T., Dougherty D.D., Rauch S.L. Functional imaging of mood and anxiety disorders. Journal of Neuroimaging 2006, 16(1):1-10.
12. Durston S., de Zeeuw P., Staal W.G. Imaging genetics in ADHD: A focus on cognitive control. Neuroscience and Biobehavioral Reviews 2009, 33(5):674-689. 〈10.1016/j.neubiorev.2008.08.009〉.
13. Eddy K.T., Dutra L., Bradley R., Westen D. A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. Clinical Psychology Review 2004, 24(8):1011-1030.
14. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L. Structured clinical interview for DSM-IV personality disorders (SCID-II): Interview and questionnaire 1997, American Psychiatric Press, Washington, DC.
15. First M. B., Spitzer R. L., Gibbon M. Williams J. B.W., (1997). Structured clinical interview for DSM-IV axis I disorders (SCID-I), clinician version, American Psychiatric Publishing, Inc.; Arlington.
16. Foa E. B., Huppert, J. D., Leiberg, S., Langner, R., Kichic, R., Hajcak, P. M. et al. (2002). The obsessive-compulsive inventory: and validation of a short version, Psychological Assessment 14 (4), 485-496.
17. Frewen P.A., Dozois D.J.A., Lanius R.A. Neuroimaging studies of psychological interventions for mood and anxiety disorders: Empirical and methodological review. Clinical Psychology Review 2008, 28(2):228-246. 〈10.1016/j.cpr.2007.05.002〉.
18. Friedlander L., Desrocher M. Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clinical Psychology Review 2006, 26(1):32-49.
19. Fydrich T., Renneberg B., Schmitz B., Wittchen H.U. SKID. Strukturiertes Klinisches Interview für DSM-IV. Achse II: Persönlichkeitsstörungen 1997, Hogrefe-Verlag, Göttingen.
20. Gönner S., Ecker W., Leonhart R. Obsessive-compulsive Inventory-Revised (OCI-R). Deutsche adaptation manual 2009, Pearson Assessment & Information, Frankfurt am Main.
21. Gönner S., Leonhart R., Ecker W. Das Zwangsinventar OCI-R-die deutsche Version des Obsessive-compulsive Inventory-Revised: Ein kurzes Selbstbeurteilungsinstrument zur mehrdimensionalen Messung von Zwangssymptomen. Psychotherapie, Psychosomatik, Medizinische Psychologie 2007, 57:395-404.
22. Gönner S., Leonhart R., Ecker W. The Obsessive-compulsive Inventory-Revised (OCI-R): Validation of the German version in a sample of patients with OCD, anxiety disorders, and depressive disorders. Journal of Anxiety Disorders 2008, 22(4):734-749.
23. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Delgado P., Heninger D.S., et al. The Yale-Brown Obsessive Compulsive Scale. II. Validity. Archives of General Psychiatry 1989, 46(11):1012-1016.
24. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill D.S., et al. The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. Archives of General Psychiatry 1989, 46(11):1006-1011.
25. Gottfried J.A., Dolan R.J. Human orbitofrontal cortex mediates extinction learning while accessing conditioned representations of value. Nature Neuroscience 2004, 7(10):1144-1152. 〈10.1038/nn1314〉.
26. Greenberg B.D., Gabriels L.A., Malone D.A., Rezai A.R., Friehs G.M., et al. Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: Worldwide experience. Molecular Psychiatry 2010, 15(1):64-79.
27. Hanakawa T., Immisch I., Toma K., Dimyan M.A., van Gelderen P., Hallett M. Functional properties of brain areas associated with motor execution and imagery. Journal of Neurophysiology 2003, 89(2):989-1002. 〈10.1152/jn.00132.2002〉.
28. Hand I., Büttner-Westphal H. Die Yale-Brown-Obsessive-Scale (Y-BOCS). Ein halbstrukturiertes Interview zur Beurteilung des Schweregrades von Denk- und Handlungszwängen. Verhaltenstherapie 1991, 1:223-225.
29. Hansen E.S., Hasselbalch S., Law I., Bolwig T.G. The caudate nucleus in obsessive-compulsive disorder. Reduced metabolism following treatment with paroxetine: a PET study. International Journal of Neuropsychopharmacology 2002, 5(01):1-10. 10.1017/S1461145701002681.
30. Hautzinger M., Keller F., Kühner C. BDI II-Beck Depressions-Inventar-Manual 2006, Harcourt Test Services, Frankfurt am Main.
31. Huey E.D., Zahn R., Krueger F., Moll J., Kapogiannis D., Wassermann J., et al. A psychological and neuroanatomical model of obsessive-compulsive disorder. Journal of Neuropsychiatry and Clinical Neurosciences 2008, 20(4):390-408.
32. Husted D.S., Shapira N.A., Goodman W.K. The neurocircuitry of obsessive-compulsive disorder and disgust. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2006, 30(3):389-399.
33. Lakatos A., Reinecker H. Kognitive Verhaltenstherapie bei Zwangsstörungen: Ein Therapiemanual 2007, Hogrefe-Verlag. 3rd ed.
34. Lang P.J., Bradley M.M., Cuthbert B.N. International affective picture system (iaps): Affective ratings of pictures and instruction manual 2008, University of Florida, Gainesville.
35. Laux L., Glanzmann P., Schaffner P., Spielberger C.D. Das State-Trait-Angstinventar: STAI 1981, Beltz Test GmbH, Weinheim.
36. Linden D.E.J. How psychotherapy changes the brain-The contribution of functional neuroimaging. Molecular Psychiatry 2006, 11(6):528-538. 10.1038/sj.mp.4001816.
37. Liotti M., Mayberg H.S., Brannan S.K., McGinnis S., Jerabek P., Fox P.T. Differential limbic-cortical correlates of sadness and anxiety in healthy subjects: Implications for affective disorders. Biological Psychiatry 2000, 48(1):30-42. 〈10.1016/S0006-3223(00)00874-X〉.
38. Mataix-Cols D., Cullen S., Lange K., Zelaya F., Andrew C., Amaro E., et al. Neural correlates of anxiety associated with obsessive-compulsive symptom dimensions in normal volunteers. Biological Psychiatry 2003, 53(6):482-493.
39. Mataix-Cols D., Lawrence N.S., Wooderson S., Speckens A., Phillips M.L. The Maudsley Obsessive-Compulsive Stimuli Set: Validation of a standardized paradigm for symptom-specific provocation in obsessive-compulsive disorder. Psychiatry Research 2009, 168(3):238-241.
40. Mataix-Cols D., Wooderson S., Lawrence N.S., Brammer M.J., Speckens A., Phillips M.L. Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. Archives of General Psychiatry 2004, 61(6):564-576.
41. Matsunaga H., Hayashida K., Kiriike N., Maebayashi K., Stein D.J. The clinical utility of symptom dimensions in obsessive-compulsive disorder. Psychiatry Research 2010, 180(1):25-29. 10.1016/j.psychres.2009.09.005.
42. McGuire P.K., Bench C.J., Frith C.D., Marks I.M., Frackowiak R.S., Dolan R.J. Functional anatomy of obsessive-compulsive phenomena. British Journal of Psychiatry 1994, 164(4):459-468.
43. Menzies L., Chamberlain S.R., Laird A.R., Thelen S.M., Sahakian B.J., Bullmore E.T. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neuroscience and Biobehavioral Reviews 2008, 32(3):525-549.
44. Milad M.R., Rauch S.L. The role of the orbitofrontal cortex in anxiety disorders. Annals of the New York Academy of Sciences 2007, 1121(1):546-561. 〈10.1196/annals.1401.006〉.
45. Muller J., Roberts J.E. Memory and attention in obsessive-compulsive disorder: A review. Journal of Anxiety Disorders 2005, 19(1):1-28. 〈10.1016/j.janxdis.2003.12.001〉.
46. Nakao, T., Nakagawa, A., Yoshiura, T., Nakatani, E., Nabeyama, M., Yoshizato, M., et al. (2005). Brain activation of patients with obsessive-compulsive disorder during neuropsychological and symptom provocation tasks before and after symptom improvement: a functional magnetic resonance imaging study, Biological Psychiatry 5757 (8), 901-910.
47. Nakatani E., Nakagawa A., Ohara Y., Goto S., Uozumi N., Iwakiri M., Yoshizato M., et al. Effects of behavior therapy on regional cerebral blood flow in obsessive-compulsive disorder. Psychiatry Research: Neuroimaging 2003, 124(2):113-120.
48. Phillips M.L., Marks I.M., Senior C., Lythgoe D., O'Dwyer A.M., Meehan P.K., et al. A differential neural response in obsessive-compulsive disorder patients with washing compared with checking symptoms to disgust. Psychological Medicine 2000, 30(5):1037-1050.
49. Porto P.R., Oliveira L., Mari J., Volchan E., Figueira I., Ventura P. Does cognitive behavioral therapy change the brain? A systematic review of neuroimaging in anxiety disorders. Journal of Neuropsychiatry and Clinical Neurosciences 2009, 21(2):114-125. 〈10.1176/appi.neuropsych.21.2.114〉.
50. Quidé, Witteveen A.B., El-Hage W., Veltman D.J., Olff M. Differences between effects of psychological versus pharmacological treatments on functional and morphological brain alterations in anxiety disorders and major depressive disorder: A systematic review. Neuroscience and Biobehavioral Reviews 2012, 36(1):626-644. 〈10.1016/j.neubiorev.2011.09.004〉.
51. Rauch S.L., Shin L.M., Dougherty D.D., Alpert N.M., Fischman A.J., Jenike M.A. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: A PET symptom provocation study. Neuropsychopharmacology 2002, 27(5):782-791.
52. Rotge J.-Y., Guehl D., Dilharreguy B., Cuny E., Tignol J., Bioulac B., et al. Provocation of obsessive-compulsive symptoms: A quantitative voxel-based meta-analysis of functional neuroimaging studies. Journal of Psychiatry & Neuroscience: JPN 2008, 33(5):405-412.
53. Rotge J.-Y., Langbour N., Guehl D., Bioulac B., Jaafari N., Allard P., Burbaud M., et al. Gray matter alterations in obsessive-compulsive disorder: an anatomic likelihood estimation meta-analysis. Neuropsychopharmacology 2010, 35(3):686-691.
54. Rushworth M.F.S., Krams M., Passingham R.E. The attentional role of the left parietal cortex: The distinct lateralization and localization of motor attention in the human brain. Journal of Cognitive Neuroscience 2001, 13(5):698-710. 〈10.1162/089892901750363244〉.
55. Salamone J.D., Correa M., Mingote S.M., Weber S.M. Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. Current Opinion in Pharmacology 2005, 5(1):34-41. 〈10.1016/j.coph.2004.09.004〉.
56. Saxena S., Brody A.L., Ho M.L., Alborzian S., Maidment K.M., Zohrabi N., et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs. major depression. Archives of Psychiatry 2003, 59(3):522-532. 〈10.1176/appi.ajp.160.3.522〉.
57. Saxena S., Gorbis E., O'Neill J., Baker S.K., Mandelkern M.A., Maidment K.M., et al. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Molecular Psychiatry 2009, 14(2):197-205. 〈10.1038/sj.mp.4002134〉.
58. Schienle A., Schäfer A., Hermann A., Walter B., Stark R., Vaitl D. fMRI responses to pictures of mutilation and contamination. Neuroscience Letters 2006, 393(2-3):174-178. 〈10.1016/j.neulet.2005.09.072〉.
59. Schienle A., Schäfer A., Stark R., Walter B., Vaitl D. Neural responses of OCD patients towards disorder-relevant, generally disgust-inducing and fear-inducing pictures. International Journal of Psychophysiology 2005, 57(1):69-77.
60. Schienle A., Walter B., Stark R., Vaitl D. Ein Fragebogen zur Erfassung der Ekelempfindlichkeit (FEE). (A questionnaire for the assessment of disgust sensitivity [QADS]). Zeitschrift für Klinische Psychologie und Psychotherapie 2002, 31(2):110-120.
61. Schiepek G., Tominschek I., Karch S., Lutz J., Mulert C., Meindl O., et al. A controlled single case study with repeated fMRI measurements during the treatment of a patient with obsessive-compulsive disorder: testing the nonlinear dynamics approach to psychotherapy. World Journal of Biological Psychiatry 2009, 10(4_2):658-668.
62. Schlaepfer T.E., Bewernick B. Modulating affect, cognition, and behavior-Prospects of deep brain stimulation for treatment-resistant psychiatric disorders. Frontiers in Integrative Neuroscience 2011, 5:29.
63. Schlaepfer T.E., Cohen M.X., Frick C., Kosel M., Brodesser D., Axmacher N., et al. Deep brain stimulation to reward circuitry alleviates anhedonia in refractory major depression. Neuropsychopharmacology 2008, 33(2):368-377. 〈10.1038/sj.npp.1301408〉.
64. Schwartz, J. M., Stoessel, P. W., Baxter, L. R. Jr., Martin, K. M. Phelps, M. E., Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder, Archives of General Psychiatry 53 (2), 1996, 109-113.
65. Shechner T., Britton J.C., Pérez-Edgar K., Bar-Haim Y., Ernst M., Fox N.A., et al. Attention biases, anxiety, and development: Toward or away from threats or rewards?. Depression and Anxiety 2012, 29(4):282-294. 〈10.1002/da.20914〉.
66. Simon D., Kaufmann C., Müsch K., Kischkel E., Kathmann N. Fronto striato limbic hyperactivation in obsessive compulsive disorder during individually tailored symptom provocation. Psychophysiology 2010, 47(4):728-738.
67. Simon D., Kischkel E., Spielberg R., Kathmann N. A pilot study on the validity of using pictures and videos for individualized symptom provocation in obsessive-compulsive disorder. Psychiatry Research 2012, 198(1):81-88.
68. Spielberger C.D., Gorsuch R.L., Lushene R.E. Manual for the state-trait anxiety inventory 1970, Consulting Psychologists Press, Palo Alto, CA.
69. Stobie B., Taylor T., Quigley A., Ewing S., Salkovskis P.M. "Contents May Vary": A pilot study of treatment histories of OCD patients. Behavioural and Cognitive Psychotherapy 2007, 35(03):273-282.
70. Szeszko P.R., Ardekani B.A., Ashtari M., Malhotra A.K., Robinson D.G., Bilder K.O., et al. White matter abnormalities in obsessive-compulsive disorder: A diffusion tensor imaging study. Archives of General Psychiatry 2005, 62(7):782-790. 〈10.1001/archpsyc.62.7.782〉.
71. Tolin D.F., Stevens M.C., Nave A., Villavicencio A.L., Morrison S. Neural mechanisms of cognitive behavioral therapy response in Hoarding Disorder: A pilot study. Journal of Obsessive-Compulsive and Related Disorders 2012, 1(3):180-188. 〈10.1016/j.jocrd.2012.04.001〉.
72. van den Heuvel O.A., Remijnse P.L., Mataix-Cols D., Vrenken H., Groenewegen H.J., Uylings H.B.M., et al. The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. Brain: A Journal of Neurology 2009, 132(Pt. 4):853-868.
73. Vandborg S.K., Hartmann T.B., Bennedsen B.E., Pedersen A.D., Eskildsen A., Videbech P.B.H., et al. Do cognitive functions in obsessive-compulsive disorder change after treatment? A systematic review and a double case report. Nordic Journal of Psychiatry 2012, 66(1):60-67. 〈10.3109/08039488.2011.626869〉.
74. Wager T.D., Davidson M., Hughes B., Lindquist M., Ochsner K. Prefrontal-subcortical pathways mediating successful emotion regulation. Neuron 2008, 59(6):1037-1050.
75. Whiteside S.P., Port J.D., Abramowitz J.S. A meta-analysis of functional neuroimaging in obsessive-compulsive disorder. Psychiatry Research: Neuroimaging 2004, 132(1):69-79.
76. Wittchen H.U., Wunderlich U., Gruschwitz S., Zaudig M. SKID. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen 1997, Hogrefe-Verlag, Göttingen.